Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3861)
All Articles published online
|
Jul 21, 2006 (publication date) through Mar 10, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kondo Y, Kobayashi K, Ueno Y, Shiina M, Niitsuma H, Kanno N, Kobayashi T, Shimosegawa T. Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B. World J Gastroenterol 2006; 12(27): 4310-4317 [PMID: 16865771 DOI: 10.3748/wjg.v12.i27.4310] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i27/4310.htm |
| Number | Citing Articles |
| 1 |
Simon M Rushbrook, Matthew Hoare, Graeme JM Alexander. T-regulatory lymphocytes and chronic viral hepatitis. Expert Opinion on Biological Therapy 2007; 7(11): 1689 doi: 10.1517/14712598.7.11.1689
|
| 2 |
Ana Ortega-Prieto, Marcus Dorner. Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection. Vaccines 2017; 5(3): 24 doi: 10.3390/vaccines5030024
|
| 3 |
Yasuteru Kondo, Yoshiyuki Ueno, Tooru Shimosegawa. Dysfunction of Immune Systems and Host Genetic Factors in Hepatitis C Virus Infection with Persistent Normal ALT. Hepatitis Research and Treatment 2011; 2011: 1 doi: 10.1155/2011/713216
|
| 4 |
Joelma Carvalho Santos, Dayse Maria Vasconcelos de Deus, Izolda Maria Fernandes de Moura, Edmundo Pessoa Lopes, Maria Rosileide Bezerra Alves, Maria Rosângela Cunha Duarte Coêlho. Association between the <b><i>IFNA1 </i></b>(-2C→T) Polymorphism and Increased <b><i>IFNAR1 </i></b>Gene Expression Levels in Chronic Hepatitis B Infection. Intervirology 2015; 58(6): 393 doi: 10.1159/000444365
|
| 5 |
Tri Nugraha Susilawati, Alfin Titian Permata, Sigit Setyawan. The immunobiology of regulatory T cells in hepatitis B and C. THE 2ND INTERNATIONAL CONFERENCE ON SCIENCE, MATHEMATICS, ENVIRONMENT, AND EDUCATION 2019; 2194: 020121 doi: 10.1063/1.5139853
|
| 6 |
Chunhua Wen, Zheyu Dong, Yiyue Wang, Guofu Ye, Yanchen Ma, Xuan Yi, Yang Zhou, Xiaoyi Li, Xinchun Zheng, Jinlin Hou, Yongyin Li, Libo Tang. CTLA4+CD4+CXCR5−FOXP3+ T cells associate with unfavorable outcome in patients with chronic HBV infection. BMC Immunology 2023; 24(1) doi: 10.1186/s12865-022-00537-w
|
| 7 |
Seyed Hossein Aalaei-Andabili, Seyed Moayed Alavian. Regulatory T cells are the most important determinant factor of hepatitis B infection prognosis: A systematic review and meta-analysis. Vaccine 2012; 30(38): 5595 doi: 10.1016/j.vaccine.2012.06.063
|
| 8 |
Sjoerd H. van der Burg, Ramon Arens, Cornelis J.M. Melief. Immunotherapy for persistent viral infections and associated disease. Trends in Immunology 2011; 32(3): 97 doi: 10.1016/j.it.2010.12.006
|
| 9 |
Yasuteru Kondo, Osamu Kimura, Tooru Shimosegawa. Significant biomarkers for the management of hepatocellular carcinoma. Clinical Journal of Gastroenterology 2015; 8(3): 109 doi: 10.1007/s12328-015-0568-9
|
| 10 |
Yasuteru Kondo, Yoshiyuki Ueno, Tooru Shimosegawa. Immunopathogenesis of hepatitis B persistent infection: implications for immunotherapeutic strategies. Clinical Journal of Gastroenterology 2009; 2(2): 71 doi: 10.1007/s12328-009-0074-z
|
| 11 |
Wei Li, Jun Han, Hong Wu. Regulatory T‐cells promote hepatitis B virus infection and hepatocellular carcinoma progression. Chronic Diseases and Translational Medicine 2016; 2(2): 67 doi: 10.1016/j.cdtm.2016.09.001
|
| 12 |
Tobias Manigold, Vito Racanelli. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. The Lancet Infectious Diseases 2007; 7(12): 804 doi: 10.1016/S1473-3099(07)70289-X
|
| 13 |
Tomoaki Iwata, Yasuteru Kondo, Osamu Kimura, Tatsuki Morosawa, Yasuyuki Fujisaka, Teruyuki Umetsu, Takayuki Kogure, Jun Inoue, Yu Nakagome, Tooru Shimosegawa. PD-L1+MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment. Scientific Reports 2016; 6(1) doi: 10.1038/srep39296
|
| 14 |
Xiao-Peng Fan, Zhi-Qiang Zou, Bo Long, Yan-Mei Guo, Si-Kui Wang, De-Xing Jia, Ai-Ling Xu, Feng-Cai Li, Yu-Chen Fan, Kai Wang. Enhanced Demethylation of Interferon-.GAMMA. Gene Promoter in Peripheral Blood Mononuclear Cells Is Associated with Acute-on-Chronic Hepatitis B Liver Failure. The Tohoku Journal of Experimental Medicine 2011; 224(1): 13 doi: 10.1620/tjem.224.13
|
| 15 |
Yasuteru Kondo, Tooru Shimosegawa. Significant Roles of Regulatory T Cells and Myeloid Derived Suppressor Cells in Hepatitis B Virus Persistent Infection and Hepatitis B Virus-Related HCCs. International Journal of Molecular Sciences 2015; 16(2): 3307 doi: 10.3390/ijms16023307
|
| 16 |
K. T. Umbetova, E. V. Volchkova, M. V. Kiselevsky, Yu. G. Parkhomenko, L. I. Shuba, S. G. Pak. MORPHOLOGICAL BASIS OF AUTOIMMUNE MANIFESTATIONS IN VIRAL HEPATITISES. Epidemiology and Infectious Diseases 2012; 17(5): 4 doi: 10.17816/EID40682
|
| 17 |
Simone R.S. Conde, Rosimar N.M. Feitosa, Felipe Bonfim Freitas, Renata B. Hermes, Samia Demachki, Marialva T.F. Araújo, Manoel C.P. Soares, Ricardo Ishak, Antonio C.R. Vallinoto. Association of cytokine gene polymorphisms and serum concentrations with the outcome of chronic hepatitis B. Cytokine 2013; 61(3): 940 doi: 10.1016/j.cyto.2013.01.004
|
| 18 |
Ming-Hui Li, Lu Zhang, Dan Zhang, Wei-Hua Cao, Tian-Lin Qi, Hong-Xiao Hao, Xing-Yue Wang, Chong-Ping Ran, Xiao-Jing Qu, Shun-Ai Liu, Yao Lu, Ge Shen, Shu-Ling Wu, Min Chang, Ru-Yu Liu, Lei-Ping Hu, Wen-Hao Hua, Gang Wan, Jun Cheng, Yao Xie. Plasmacytoid Dendritic Cell Function and Cytokine Network Profiles in Patients with Acute or Chronic Hepatitis B Virus Infection. Chinese Medical Journal 2018; 131(1): 43 doi: 10.4103/0366-6999.221275
|
| 19 |
Hsiu-Ting Tsai, Tzu-Hsin Tsai, Tsong-Ming Lu, Chi-Chiang Yang. Immunopathology of Hepatitis B Virus Infection. International Reviews of Immunology 2008; 27(6): 427 doi: 10.1080/08830180802295757
|
| 20 |
Kirsten K. Dietze, Simone Schimmer, Freya Kretzmer, Junzhong Wang, Yong Lin, Xuan Huang, Weimin Wu, Baoju Wang, Mengji Lu, Ulf Dittmer, Dongliang Yang, Jia Liu, Antonio A Freitas. Characterization of the Treg Response in the Hepatitis B Virus Hydrodynamic Injection Mouse Model. PLOS ONE 2016; 11(3): e0151717 doi: 10.1371/journal.pone.0151717
|
| 21 |
Ye Zhang, Jian-Qi Lian, Chang-Xing Huang, Jiu-Ping Wang, Xin Wei, Xue-Ping Nan, Hai-Tao Yu, Li-Li Jiang, Xiao-Qin Wang, Yan Zhuang, Xin-Hong Li, Yu Li, Ping-Zhong Wang, Michael D. Robek, Xue-Fan Bai. Overexpression of Toll-like receptor 2/4 on monocytes modulates the activities of CD4+CD25+ regulatory T cells in chronic hepatitis B virus infection. Virology 2010; 397(1): 34 doi: 10.1016/j.virol.2009.11.007
|
| 22 |
Ping Lei, Guan-Xin Shen, Fu-Sheng Wang, Qin Ning, Hong Ren, Wei-Ming Yan, Di Wu. Acute Exacerbation of Chronic Hepatitis B. 2019; : 223 doi: 10.1007/978-94-024-1606-0_5
|
| 23 |
Wendi Zhang, Haoyu Sun, Rui Sun, Zhexiong Lian, Haiming Wei, Zhigang Tian, Yongyan Chen. HBV immune tolerance of HBs-transgenic mice observed through parabiosis with WT mice. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.993246
|
| 24 |
Roba M. Talaat, Mahmoud F. Dondeti, Soha Z. El-Shenawy, Omaima A. Khamiss. Association Between IL-10 Gene Promoter Polymorphism and Hepatitis B Viral Infection in an Egyptian Population. Biochemical Genetics 2014; 52(9-10): 387 doi: 10.1007/s10528-014-9655-8
|
| 25 |
Luisa Barboza, Siham Salmen, Loredana Goncalves, Melisa Colmenares, Darrell Peterson, Henry Montes, Raimondo Cartagirone, Maria del Carmen Gutiérrez, Lisbeth Berrueta. Antigen-induced regulatory T cells in HBV chronically infected patients. Virology 2007; 368(1): 41 doi: 10.1016/j.virol.2007.06.030
|
| 26 |
Yasuteru Kondo, Yoshiyuki Ueno, Tooru Shimosegawa. Toll-Like Receptors Signaling Contributes to Immunopathogenesis of HBV Infection. Gastroenterology Research and Practice 2011; 2011: 1 doi: 10.1155/2011/810939
|
| 27 |
Anthony Tanoto Tan, Sarene Koh, Vera Goh, Antonio Bertoletti. Understanding the immunopathogenesis of chronic hepatitis B virus: An Asian prospective. Journal of Gastroenterology and Hepatology 2008; 23(6): 833 doi: 10.1111/j.1440-1746.2008.05385.x
|
| 28 |
Leonardo Fainboim, Alejandra Cherñavsky, Natalia Paladino, Ana C. Flores, Lourdes Arruvito. Cytokines and chronic liver disease. Cytokine & Growth Factor Reviews 2007; 18(1-2): 143 doi: 10.1016/j.cytogfr.2007.01.017
|
| 29 |
Ming‐hui Li, Qi‐qi Chen, Lu Zhang, Hui‐hui Lu, Fang‐fang Sun, Zhan Zeng, Yao Lu, Wei Yi, Yao Xie. Association of cytokines with hepatitis B virus and its antigen. Journal of Medical Virology 2020; 92(12): 3426 doi: 10.1002/jmv.26301
|
| 30 |
Yasuteru Kondo, Yoshiyuki Ueno, Masashi Ninomiya, Keiichi Tamai, Yasuhito Tanaka, Jun Inoue, Eiji Kakazu, Koju Kobayashi, Osamu Kimura, Masahito Miura, Takeshi Yamamoto, Tomoo Kobayashi, Takehiko Igarashi, Tooru Shimosegawa. Sequential immunological analysis of HBV/HCV co-infected patients during Peg-IFN/RBV therapy. Journal of Gastroenterology 2012; 47(12): 1323 doi: 10.1007/s00535-012-0596-x
|
| 31 |
Yasuteru Kondo, Osamu Kimura, Yasuhito Tanaka, Masashi Ninomiya, Tomoaki Iwata, Takayuki Kogure, Jun Inoue, Masaya Sugiyama, Tatsuki Morosawa, Yasuyuki Fujisaka, Tooru Shimosegawa, J.-H. J. Ou.
Differential Expression of CX3CL1 in Hepatitis B Virus-Replicating Hepatoma Cells Can Affect the Migration Activity of CX3CR1
+
Immune Cells
. Journal of Virology 2015; 89(14): 7016 doi: 10.1128/JVI.00716-15
|
| 32 |
Mengjun Zhang, Jijun Zhou, Tingting Zhao, Guangyu Huang, Yulong Tan, Shun Tan, Xiaolan Fu, Wei Niu, Gang Meng, Xiaoling Chen, Xiaoyun Shang, Dong Liu, Bing Ni, Li Wang, Yuzhang Wu. Dissection of a Circulating and Intrahepatic CD4+Foxp3+ T-Cell Subpopulation in Chronic Hepatitis B Virus (HBV) Infection: A Highly Informative Strategy for Distinguishing Chronic HBV Infection States. The Journal of Infectious Diseases 2012; 205(7): 1111 doi: 10.1093/infdis/jis011
|
| 33 |
Anwar Parvez, Aparajita Das, Ashik Mahmud, Partha Biswas, Md Hasibul Hasan, Sadia Jannat Tauhida, Md. Saqline Mostaq, Md. Mahedi Hasan Nahid, Farzana Ansari, Saikat Fakir, Mohammad Nurul Amin. Mechanistic insights of clinically proven natural products in the treatment of hepatitis B focusing on clinical evidence and pathways. Clinical Traditional Medicine and Pharmacology 2024; 5(4): 200183 doi: 10.1016/j.ctmp.2024.200183
|
| 34 |
Antonio Bertoletti, Adam Gehring. Therapeutic vaccination and novel strategies to treat chronic HBV infection. Expert Review of Gastroenterology & Hepatology 2009; 3(5): 561 doi: 10.1586/egh.09.48
|
| 35 |
Yasuteru Kondo, Masashi Ninomiya, Eiji Kakazu, Osamu Kimura, Tooru Shimosegawa. Hepatitis B Surface Antigen Could Contribute to the Immunopathogenesis of Hepatitis B Virus Infection. ISRN Gastroenterology 2013; 2013: 1 doi: 10.1155/2013/935295
|
| 36 |
Xue-Ping Nan, Ye Zhang, Hai-Tao Yu, Rui-Lin Sun, Mei-Juan Peng, Yu Li, Wen-Jing Su, Jian-Qi Lian, Jiu-Ping Wang, Xue-Fan Bai. Inhibition of Viral Replication Downregulates CD4+CD25highRegulatory T Cells and Programmed Death-Ligand 1 in Chronic Hepatitis B. Viral Immunology 2012; 25(1): 21 doi: 10.1089/vim.2011.0049
|
| 37 |
YI CHEN, JIANKAI FANG, XUZHENG CHEN, CHEN PAN, XIAOLONG LIU, JINGFENG LIU. Effects of the Treg/Th17 cell balance and their associated cytokines in patients with hepatitis B infection. Experimental and Therapeutic Medicine 2015; 9(2): 573 doi: 10.3892/etm.2014.2104
|
| 38 |
Xingyue Zeng, Ayibaota Bahabayi, Bulidierxin Tuerhanbayi, Mohan Zheng, Tianci Liu, Lijuan Xu, Yan Long, Changsheng Xia, Songsong Lu, Ying Song, Chen Liu. The altered HLA‐DQ expression in peripheral blood T cells of chronic hepatitis B patients characterizes the function of T cells. Journal of Viral Hepatitis 2022; 29(5): 340 doi: 10.1111/jvh.13669
|
| 39 |
Jian Ge, Kai Wang, Qing-Hua Meng, Zhao-Xia Qi, Fan-Li Meng, Yu-Chen Fan. Implication of Th17 and Th1 Cells in Patients with Chronic Active Hepatitis B. Journal of Clinical Immunology 2010; 30(1): 60 doi: 10.1007/s10875-009-9328-2
|
| 40 |
Tian-Yang Li, Yang Yang, Guo Zhou, Zheng-Kun Tu. Immune suppression in chronic hepatitis B infection associated liver disease: A review. World Journal of Gastroenterology 2019; 25(27): 3527-3537 doi: 10.3748/wjg.v25.i27.3527
|
| 41 |
Hui Wan, Yu-Xin Zhang, Guan-Yue Shan, Jun-Ya Cheng, Duan-Rui Qiao, Yi-Ying Liu, Wen-Na Shi, Hai-Jun Li. Antiviral therapy for hepatitis B virus infection is beneficial for the prognosis hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2025; 17(1): 93983 doi: 10.4251/wjgo.v17.i1.93983
|
| 42 |
Roy O. Mathew, Darius L. Mason, Renjie Song, Tiffany Tryniszewski, Jeffrey S. Kennedy. Role of T‐regulatory cells in the response to hepatitis B vaccine in hemodialysis patients. Hemodialysis International 2016; 20(2): 242 doi: 10.1111/hdi.12326
|
| 43 |
Antonio Bertoletti, Anthony T. Tan, Adam J. Gehring. HBV-Specific Adaptive Immunity. Viruses 2009; 1(2): 91 doi: 10.3390/v1020091
|
| 44 |
Ke-jia Wu, Qu-fei Qian, Jin-ren Zhou, Dong-lin Sun, Yun-fei Duan, Xi Zhu, Kurt Sartorius, Yun-jie Lu. Regulatory T cells (Tregs) in liver fibrosis. Cell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01347-8
|
| 45 |
Wei Yuan, Da Huang, Di Wu, Yuying Chen, Ke Ma, Meifang Han, Xiaoping Luo, Weiming Yan, Qin Ning. Pegylated Interferon-ɑ (IFN-ɑ) Enhances the Inhibitory Effect of Natural Killer Cells on Regulatory T Cells via IFN-γ in Chronic Hepatitis B. The Journal of Infectious Diseases 2021; 224(11): 1878 doi: 10.1093/infdis/jiab216
|